Mission GBM

Home
Glossary of Terms
Brain Cancer News
Brain Cancer Science Talk
Clinical Trials
FAQs
Goals of Care
Investing in Brain Cancer
Julie's Journey
Meet the Team
Archive
About

Investing in Brain Cancer

Postcards from the Field
Some green shoots of investing progress as MissionGBM welcomes its 300th case
 • 
Scott L. Rakestraw, PhD
Investing in Brain Cancer – Part 5
Models Designed to Bridge to Institutional & Strategic Investors
 • 
Scott L. Rakestraw, PhD
Investing in Brain Cancer - Part 4
Patient Advocacy Groups, Foundations & Family Offices
 • 
Scott L. Rakestraw, PhD
Investing in Brain Cancer - Part 3b
Strategic Investor Perspective
 • 
Scott L. Rakestraw, PhD
Investing in Brain Cancer - Part 3a
Institutional Investor Perspective
 • 
Scott L. Rakestraw, PhD
28:05
Investing in Brain Cancer - Part 2
Therapeutic Strategy…with some Business & Investment Strategy sprinkled in
 • 
Scott L. Rakestraw, PhD
MimiVax Announces New Investments to Support Clinical Development of SurVaxM in Glioblastoma
Example of a transitional model for financing brain cancer therapeutics development
 • 
Scott L. Rakestraw, PhD
Investing in Brain Cancer - Part 1
Scope of the Challenge
 • 
Scott L. Rakestraw, PhD
Stanford's Innovative Medicines Accelerator and The Invus Group Collaborate to Attack GBM
An important and visionary partnership featuring multiple members of Team Julie
 • 
Scott L. Rakestraw, PhD
Can We Talk? Starting Important Conversations About Increasing Investment in Brain Cancer R&D
Multiple, independent R&D streams and major investor discussions are converging on a set of new models for accelerating brain cancer therapeutics…
 • 
Scott L. Rakestraw, PhD
© 2024 Scott L. Rakestraw, PhD
Privacy ∙ Terms ∙ Collection notice
Start WritingGet the app
Substack is the home for great culture